Cisplatin nephrotoxicity: a summary of preventative interventions

Area of Science:

• Oncology
• Nephrology
• Pharmacology

Background:

• Cisplatin is a widely used chemotherapy agent with significant nephrotoxicity.
• Nephrotoxicity from cisplatin is dose-related, cumulative, and can be severe.
• Existing interventions aim to mitigate cisplatin-induced kidney damage.

Purpose of the Study:

• To review interventions for ameliorating cisplatin nephrotoxicity.
• To highlight recent findings on hypertonic NaCl 0.9% in reducing nephrotoxicity.
• To discuss the development of newer platinum analogs with reduced toxicity.

Main Methods:

• Literature review of interventions for cisplatin nephrotoxicity.
• Summary of evaluated methods including hydration, diuretics, and infusion time alterations.
• Inclusion of recent findings on hypertonic NaCl and new platinum analogs.

Main Results:

• Various interventions like hydration and diuretics have been evaluated.
• Hypertonic NaCl 0.9% shows promise in decreasing cisplatin nephrotoxicity incidence.
• Newer platinum analogs are under investigation for improved safety profiles.

Conclusions:

• Cisplatin nephrotoxicity is a significant clinical challenge.
• Hypertonic NaCl 0.9% represents a potential strategy to reduce kidney damage.
• Development of less toxic platinum analogs is ongoing to improve cancer treatment outcomes.